These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Targeting lung cancer stem-like cells with TRAIL gene armed oncolytic adenovirus. Yang Y; Xu H; Huang W; Ding M; Xiao J; Yang D; Li H; Liu XY; Chu L J Cell Mol Med; 2015 May; 19(5):915-23. PubMed ID: 25683371 [TBL] [Abstract][Full Text] [Related]
5. An armed oncolytic adenovirus ZD55-IL-24 combined with ADM or DDP demonstrated enhanced antitumor effect in lung cancer. Zhong S; Yu D; Wang Y; Qiu S; Wu S; Liu XY Acta Oncol; 2010; 49(1):91-9. PubMed ID: 19734998 [TBL] [Abstract][Full Text] [Related]
6. [Construction of an oncolytic adenovirus expressing small hairpin RNA and targeting the SATB1 gene]. Mao LJ; Zheng JN; Li W; Wang JQ; Chen JC; Sun XQ Zhonghua Nan Ke Xue; 2010 Aug; 16(8):679-83. PubMed ID: 21090340 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA. Zheng JN; Pei DS; Mao LJ; Liu XY; Mei DD; Zhang BF; Shi Z; Wen RM; Sun XQ Cancer Gene Ther; 2009 Jan; 16(1):20-32. PubMed ID: 18690204 [TBL] [Abstract][Full Text] [Related]
8. Human sodium iodide symporter added to multidrug resistance 1 small hairpin RNA in a single gene construct enhances the therapeutic effects of radioiodine in a nude mouse model of multidrug resistant colon cancer. Jeon YH; Ahn SJ; Lee YJ; Lee YL; Lee SW; Park SY; Kim IS; Ahn BC; Ha JH; Lee J Cancer Biother Radiopharm; 2010 Dec; 25(6):671-9. PubMed ID: 21204761 [TBL] [Abstract][Full Text] [Related]
9. Oncolytic virus carrying shRNA targeting SATB1 inhibits prostate cancer growth and metastasis. Mao LJ; Zhang J; Liu N; Fan L; Yang DR; Xue BX; Shan YX; Zheng JN Tumour Biol; 2015 Nov; 36(11):9073-81. PubMed ID: 26084613 [TBL] [Abstract][Full Text] [Related]
10. Combination of ZD55-MnSOD therapy with 5-FU enhances antitumor efficacy in colorectal cancer. Zhang Y; Qin X; Zhang Y; Zhao L; Wang Y; Liu X; Yao L J Cancer Res Clin Oncol; 2008 Feb; 134(2):219-26. PubMed ID: 17632733 [TBL] [Abstract][Full Text] [Related]
11. VEGI-armed oncolytic adenovirus inhibits tumor neovascularization and directly induces mitochondria-mediated cancer cell apoptosis. Xiao T; Fan JK; Huang HL; Gu JF; Li LY; Liu XY Cell Res; 2010 Mar; 20(3):367-78. PubMed ID: 19918267 [TBL] [Abstract][Full Text] [Related]
12. A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma. Wang Y; Liu T; Huang P; Zhao H; Zhang R; Ma B; Chen K; Huang F; Zhou X; Cui C; Liu X Oncotarget; 2015 May; 6(15):13564-78. PubMed ID: 25980438 [TBL] [Abstract][Full Text] [Related]
13. Silencing Daxx increases the anti-tumor activity of a TRAIL/shRNA Bcl-xL-expressing oncolytic adenovirus through enhanced viral replication and cellular arrest. Kang S; Kang D; Bakhtiar Ul Islam SM; Je S; Kim JH; Song JJ Cell Signal; 2015 Jun; 27(6):1214-24. PubMed ID: 25748050 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of renal cancer cell growth by oncolytic adenovirus armed short hairpin RNA targeting hTERT gene. Zheng JN; Pei DS; Sun FH; Zhang BF; Liu XY; Gu JF; Liu YH; Hu XL; Mao LJ; Wen RM; Liu JJ; Li W Cancer Biol Ther; 2009 Jan; 8(1):84-91. PubMed ID: 19029834 [TBL] [Abstract][Full Text] [Related]
15. Targeted Hsp70 expression combined with CIK-activated immune reconstruction synergistically exerts antitumor efficacy in patient-derived hepatocellular carcinoma xenograft mouse models. Hu H; Qiu Y; Guo M; Huang Y; Fang L; Peng Z; Ji W; Xu Y; Shen S; Yan Y; Huang X; Zheng J; Su C Oncotarget; 2015 Jan; 6(2):1079-89. PubMed ID: 25473902 [TBL] [Abstract][Full Text] [Related]
16. Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cells. Haber M; Bordow SB; Gilbert J; Madafiglio J; Kavallaris M; Marshall GM; Mechetner EB; Fruehauf JP; Tee L; Cohn SL; Salwen H; Schmidt ML; Norris MD Oncogene; 1999 Apr; 18(17):2777-82. PubMed ID: 10348353 [TBL] [Abstract][Full Text] [Related]
17. A new oncolytic adenoviral vector carrying dual tumour suppressor genes shows potent anti-tumour effect. Liu XR; Cai Y; Cao X; Wei RC; Li HL; Zhou XM; Zhang KJ; Wu S; Qian QJ; Cheng B; Huang K; Liu XY J Cell Mol Med; 2012 Jun; 16(6):1298-309. PubMed ID: 21794078 [TBL] [Abstract][Full Text] [Related]
18. Antitumor activities of an oncolytic adenovirus equipped with a double siRNA targeting Ki67 and hTERT in renal cancer cells. Fang L; Cheng Q; Li W; Liu J; Li L; Xu K; Zheng J Virus Res; 2014 Mar; 181():61-71. PubMed ID: 24463503 [TBL] [Abstract][Full Text] [Related]
19. Antitumor effects of oncolytic adenovirus armed with Drosophila melanogaster deoxyribonucleoside kinase in colorectal cancer. Ma S; Qu W; Mao L; Zhu Z; Jia L; Zhao L; Zheng X Oncol Rep; 2012 May; 27(5):1443-50. PubMed ID: 22294034 [TBL] [Abstract][Full Text] [Related]
20. Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene. Cao X; Yang M; Wei RC; Zeng Y; Gu JF; Huang WD; Yang DQ; Li HL; Ding M; Wei N; Zhang KJ; Xu B; Liu XR; Qian QJ; Liu XY Gene Ther; 2011 Aug; 18(8):765-77. PubMed ID: 21412282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]